BeOne Medicines Ltd.
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302188% above fair value
$355.00−6.27 (-1.74%)
Close on Nov 3, 2026Market cap $40.36BP/E 63.5Yield –
BeOne Medicines Raw Materials Inventory: $236M in FY2025, up 38.5% from a year earlier.
Latest, FY2025
236
Period ended Dec 31, 2025
Change on a year earlier
+38.5%
171 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Inventories Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Raw Materials Inventory ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 236 | +38.5% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 171 | +14.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 149 | +67.2% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 89 | +14.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 78.1 | +304.7% | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 19.3 | – | Form 10-K (filed 2022-02-28) ↗ |
| FY2019 | Dec 31, 2019 | 0 | – | Form 10-K (filed 2021-02-25) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Raw Materials Inventory ($M), annual FY2019–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/inv-raw
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.
See a number that looks wrong?